Amedeo Smart

Free Medical Literature Service



Autoimmune Disorders

  Free Subscription

Articles published in
J Nephrol
    September 2022
  1. SEIKRIT C, Schimpf JI, Wied S, Stamellou E, et al
    Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational study.
    J Nephrol. 2022 Sep 15. pii: 10.1007/s40620-022-01454.
    >> Share

  2. XU L, Kant S, Aqeel F, Antiochos B, et al
    Urinary cell mRNA profiling distinguishes disease activity in antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    J Nephrol. 2022 Sep 9. pii: 10.1007/s40620-022-01460.
    >> Share

    August 2022
  3. TAMPE D, Baier E, Hakroush S, Tampe B, et al
    Comparative analysis of complement C3 and C4 serum levels for outcome prediction in ANCA-associated renal vasculitis.
    J Nephrol. 2022 Aug 13. pii: 10.1007/s40620-022-01414.
    >> Share

  4. STEFAN G, Zugravu A, Stancu S
    Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy.
    J Nephrol. 2022 Aug 12. pii: 10.1007/s40620-022-01426.
    >> Share

    July 2022
  5. WU Q, Liang D, Song T, Ni X, et al
    Poor outcomes of proliferative glomerulonephritis with monoclonal IgG deposits in renal allografts: a retrospective multicenter study.
    J Nephrol. 2022 Jul 22. pii: 10.1007/s40620-022-01385.
    >> Share

  6. XIE M, Zhu Y, Wang X, Ren J, et al
    Predictive prognostic value of glomerular C3 deposition in IgA nephropathy.
    J Nephrol. 2022 Jul 4. pii: 10.1007/s40620-022-01363.
    >> Share

    May 2022
    The heritage of Thomas Addis: why do nephrologists still love glomerulonephritis?
    J Nephrol. 2022 May 11. pii: 10.1007/s40620-022-01343.
    >> Share

  8. OKI R, Unagami K, Taneda S, Takagi T, et al
    Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature.
    J Nephrol. 2022 May 6. pii: 10.1007/s40620-022-01332.
    >> Share

  9. TAMPE D, Hakroush S, Biggemann L, Winkler MS, et al
    Kinetics of human leukocyte antigen receptor HLA-DR(+) monocytes and T lymphocytes during remission induction therapy in ANCA-associated vasculitis.
    J Nephrol. 2022;35:1283-1287.
    >> Share

  10. TESAR V, Hruskova Z
    Extrarenal complications of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) and their impact on the outcome of the patients.
    J Nephrol. 2022;35:1065-1068.
    >> Share

  11. MAKATI D, Akers J, Aljuhani M, Pellegrino B, et al
    Prevalence of ANCA-associated vasculitis amid natural gas drilling sites in West Virginia.
    J Nephrol. 2022;35:1185-1192.
    >> Share

    April 2022
  12. LIU M, Yu X, Wang S, Qin A, et al
    Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes.
    J Nephrol. 2022 Apr 23. pii: 10.1007/s40620-022-01317.
    >> Share

  13. DUAN T, Zhu X, Zhao Q, Xiao L, et al
    Association of Bowman's capsule rupture with prognosis in patients with lupus nephritis.
    J Nephrol. 2022 Apr 18. pii: 10.1007/s40620-022-01316.
    >> Share

  14. HAKROUSH S, Kluge IA, Baier E, Korsten P, et al
    pANCA autoantibody testing by indirect immunofluorescence indicates interstitial arteritis independent of MPO-ANCA immunoassays in ANCA-associated glomerulonephritis.
    J Nephrol. 2022 Apr 5. pii: 10.1007/s40620-022-01320.
    >> Share

    March 2022
  15. RUAN Y, Hong F, Wu J, Lin M, et al
    Clinicopathological characteristics, risk factors and renal outcome in IgA nephropathy with crescents.
    J Nephrol. 2022 Mar 15. pii: 10.1007/s40620-022-01273.
    >> Share

  16. DEL VECCHIO L, Locatelli F, Ponticelli C
    The treatment of membranous nephropathy: a journey in the search for evidence.
    J Nephrol. 2022 Mar 1. pii: 10.1007/s40620-022-01291.
    >> Share

  17. REZAC J, Honsova E, Masek M, Rysava R, et al
    Granulomatosis with polyangiitis mimicking cancer: a diagnostic dilemma.
    J Nephrol. 2022;35:675-678.
    >> Share

    February 2022
  18. FAUCON AL, Cereja S, Mussini C, Goujon JM, et al
    Filgrastim-induced recurrent macroscopic hematuria in a patient with DNAJB9 positive fibrillary glomerulonephritis.
    J Nephrol. 2022 Feb 24. pii: 10.1007/s40620-022-01278.
    >> Share

  19. BOSE B, Chung EYM, Hong R, Strippoli GFM, et al
    Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.
    J Nephrol. 2022 Feb 23. pii: 10.1007/s40620-022-01268.
    >> Share

    December 2021
  20. HAKROUSH S, Tampe B
    Neutrophils associate with Bowman's capsule rupture specifically in PR3-ANCA glomerulonephritis.
    J Nephrol. 2021 Dec 1. pii: 10.1007/s40620-021-01208.
    >> Share

  21. WANG K, Yu Z, Huang Y, Yang K, et al
    Clinicopathological features, risk factors, and outcomes of immunoglobulin A nephropathy associated with hepatitis B virus infection.
    J Nephrol. 2021;34:1887-1896.
    >> Share

    November 2021
  22. CHENG YJ, Cheng XY, Zhang YM, Wang F, et al
    Effects of hydroxychloroquine on proteinuria in membranous nephropathy.
    J Nephrol. 2021 Nov 30. pii: 10.1007/s40620-021-01182.
    >> Share

  23. CALISKAN Y, Demir E, Karatay E, Ozluk Y, et al
    Oxidative stress and macrophage infiltration in IgA nephropathy.
    J Nephrol. 2021 Nov 16. pii: 10.1007/s40620-021-01196.
    >> Share

  24. MANENTI L, Rossi GM, Pisani I, Gentile M, et al
    IgA nephropathy and atypical hemolytic uremic syndrome: a case series and a literature review.
    J Nephrol. 2021 Nov 10. pii: 10.1007/s40620-021-01189.
    >> Share

  25. HAKROUSH S, Gersmann AK, Tampe B
    Histopathological and ultrastructural monitoring of remission induction in crescentic C3 glomerulonephritis.
    J Nephrol. 2021 Nov 6. pii: 10.1007/s40620-021-01169.
    >> Share

    October 2021
  26. GUO Y, Shi S, Zhou X, Liu L, et al
    The effect of immunosuppressive therapy in patients with fibrinoid necrosis lesions in a large cohort of patients with IgA nephropathy.
    J Nephrol. 2021 Oct 21. pii: 10.1007/s40620-021-01176.
    >> Share

  27. VAJGEL G, Correia MRB, Costa CLC, Sette LH, et al
    Nephrology pictures: pemphigus vulgaris and membranous nephropathy.
    J Nephrol. 2021 Oct 15. pii: 10.1007/s40620-021-01151.
    >> Share

  28. GUO W, Tan PH, Baikunje S
    Membranous nephropathy in a patient with COVID-19 infection.
    J Nephrol. 2021 Oct 7. pii: 10.1007/s40620-021-01165.
    >> Share

  29. JARRICK S, Lundberg S, Stephansson O, Symreng A, et al
    Pregnancy outcomes in women with immunoglobulin A nephropathy: a nationwide population-based cohort study.
    J Nephrol. 2021;34:1591-1598.
    >> Share

    September 2021
  30. MASSET C, Renaudin K, Kervella D, Chapelet A, et al
    Collapsing glomerulopathy in a patient with APOL1 intermediate-risk genotype triggered by lupus nephritis and SARS-CoV-2 infection: lessons for the clinical nephrologist.
    J Nephrol. 2021 Sep 24. pii: 10.1007/s40620-021-01144.
    >> Share

    July 2021
  31. LUAN R, Tian G, Zhang H, Shi X, et al
    Urinary exosomal circular RNAs of sex chromosome origin are associated with gender-related risk differences of clinicopathological features in patients with IgA nephropathy.
    J Nephrol. 2021 Jul 22. pii: 10.1007/s40620-021-01118.
    >> Share

  32. KANT S, Arend LJ, Gapud E, Seo P, et al
    Characterization of interstitial infiltrates in MPO and PR3 anti-neutrophil cytoplasmic antibody glomerulonephritis.
    J Nephrol. 2021 Jul 20. pii: 10.1007/s40620-021-01126.
    >> Share

    June 2021
  33. GEETHA D, Attarwala N, Zhang C, Kant S, et al
    Serum and urinary metabolites discriminate disease activity in ANCA associated glomerulonephritis in a pilot study.
    J Nephrol. 2021 Jun 28. pii: 10.1007/s40620-021-01095.
    >> Share

  34. BINET Q, Aydin S, Lengele JP, Cambier JF, et al
    Lessons for the clinical nephrologist: an uncommon cause of pulmonary-renal syndrome.
    J Nephrol. 2021;34:935-938.
    >> Share

    May 2021
  35. NAGAI M, Kobayashi N, Izumi N, Ohbayashi T, et al
    Pre-treatment hematuria and crescents predict estimated glomerular filtration rate trajectory after methylprednisolone pulse therapy with tonsillectomy for IgA nephropathy.
    J Nephrol. 2021 May 20. pii: 10.1007/s40620-021-01064.
    >> Share

    March 2021
    A sad anniversary, one year of COVID-19 epidemics-in this issue: from COVID-19 to membranous nephropathy.
    J Nephrol. 2021 Mar 26. pii: 10.1007/s40620-021-01031.
    >> Share

  37. GENTILE M, Rossi GM, Delsante M, Zambrano C, et al
    Atypical hemolytic uremic syndrome complicating relapsing cryoglobulinemic membranoproliferative glomerulonephritis despite hepatitis C eradication.
    J Nephrol. 2021 Mar 17. pii: 10.1007/s40620-021-00998.
    >> Share

  38. GOMES MF, Mardones C, Xipell M, Blasco M, et al
    The extent of tubulointerstitial inflammation is an independent predictor of renal survival in lupus nephritis.
    J Nephrol. 2021 Mar 15. pii: 10.1007/s40620-021-01007.
    >> Share

  39. ALKHATIB MH, Kant S, Menez S, Lakhani L, et al
    Thrombotic microangiopathy versus class IV lupus nephritis in systemic lupus erythematosus.
    J Nephrol. 2021 Mar 10. pii: 10.1007/s40620-021-01010.
    >> Share

  40. HAMROUN A, Lenain R, Gibier JB, Maanaoui M, et al
    Nephrology picture: intraglomerular metastases, an exceptional cause of glomerulonephritis.
    J Nephrol. 2021 Mar 9. pii: 10.1007/s40620-021-00999.
    >> Share

    February 2021
  41. TANG C, Lv JC, Shi SF, Chen YQ, et al
    Long-term safety and efficacy of hydroxychloroquine in patients with IgA nephropathy: a single-center experience.
    J Nephrol. 2021 Feb 16. pii: 10.1007/s40620-021-00988.
    >> Share

  42. STRUFALDI FL, Menezes Neves PDMM, Dias CB, Yu L, et al
    Renal thrombotic microangiopathy associated to worse renal prognosis in Lupus Nephritis.
    J Nephrol. 2021 Feb 11. pii: 10.1007/s40620-020-00938.
    >> Share

  43. KANT S, Morris A, Ravi S, Floyd L, et al
    The impact of COVID-19 pandemic on patients with ANCA associated vasculitis.
    J Nephrol. 2021;34:185-190.
    >> Share

    January 2021
  44. HOGAN JJ, Zee J, Beck LH
    Towards optimizing use of PLA2R antibody testing in membranous nephropathy.
    J Nephrol. 2021 Jan 27. pii: 10.1007/s40620-021-00971.
    >> Share

  45. DOMINGUEZ B, Vigo R
    Hypocomplementemic urticarial vasculitis syndrome associated with rapidly progressive glomerulonephritis: lessons for the clinical nephrologist.
    J Nephrol. 2021 Jan 12. pii: 10.1007/s40620-020-00942.
    >> Share

  46. LIU MY, Wang SX, Dong Y, Zhou FD, et al
    Pregnancy-associated proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
    J Nephrol. 2021 Jan 4. pii: 10.1007/s40620-020-00894.
    >> Share

  47. OTO OA, Demir E, Mirioglu S, Dirim AB, et al
    Clinical significance of glomerular C3 deposition in primary membranous nephropathy.
    J Nephrol. 2021 Jan 2. pii: 10.1007/s40620-020-00915.
    >> Share

    December 2020
  48. EDER M, Kozakowski N, Omic H, Aigner C, et al
    Glomerular C4d in Post-Transplant IgA Nephropathy is associated with decreased allograft survival.
    J Nephrol. 2020 Dec 11. pii: 10.1007/s40620-020-00914.
    >> Share

    October 2020
  49. PORCELLI B, Guarnieri A, Ferretti F, Garosi G, et al
    Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience.
    J Nephrol. 2020 Oct 29. pii: 10.1007/s40620-020-00888.
    >> Share

  50. SCHMIDT T, Schulze M, Harendza S, Hoxha E, et al
    Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab.
    J Nephrol. 2020 Oct 7. pii: 10.1007/s40620-020-00874.
    >> Share

    August 2020
  51. LENNARTZ DP, Seikrit C, Wied S, Fitzner C, et al
    Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy.
    J Nephrol. 2020 Aug 27. pii: 10.1007/s40620-020-00836.
    >> Share

  52. PEREZ-HERNANDEZ J, Martinez-Arroyo O, Ortega A, Galera M, et al
    Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis.
    J Nephrol. 2020 Aug 16. pii: 10.1007/s40620-020-00832.
    >> Share

  53. WANG R, Wang M, Xia Z, Gao C, et al
    Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases.
    J Nephrol. 2020 Aug 8. pii: 10.1007/s40620-020-00816.
    >> Share

    July 2020
  54. ANGELETTI A, Leventhal JS, Cravedi P
    Membranous nephropathy: setting the bar for hypothesis-driven, selective therapies in nephrology.
    J Nephrol. 2020 Jul 18. pii: 10.1007/s40620-020-00806.
    >> Share

    June 2020
  55. FENOGLIO R, Baldovino S, Sciascia S, De Simone E, et al
    Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli's regimen in membranous nephropathy.
    J Nephrol. 2020 Jun 27. pii: 10.1007/s40620-020-00781.
    >> Share

  56. LIANG S, Chen D, Liang D, Xu F, et al
    Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker.
    J Nephrol. 2020 Jun 18. pii: 10.1007/s40620-020-00783.
    >> Share

  57. PONTICELLI C, Doria A, Moroni G
    Renal disorders in rheumatologic diseases: the spectrum is changing (Part 1: connective tissue diseases).
    J Nephrol. 2020 Jun 11. pii: 10.1007/s40620-020-00772.
    >> Share

  58. TAO T, Wang J, Lei S, Hu Z, et al
    Identical twins with idiopathic membranous nephropathy.
    J Nephrol. 2020 Jun 10. pii: 10.1007/s40620-020-00770.
    >> Share

  59. WU H, Fang X, Xia Z, Gao C, et al
    Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
    J Nephrol. 2020 Jun 7. pii: 10.1007/s40620-020-00767.
    >> Share

    May 2020
  60. PONTICELLI C, Podesta MA
    Calcineurin inhibitors in lupus nephritis.
    J Nephrol. 2020 May 27. pii: 10.1007/s40620-020-00757.
    >> Share

  61. ARGOLINI LM, Frontini G, Elefante E, Saccon F, et al
    Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up.
    J Nephrol. 2020 May 27. pii: 10.1007/s40620-020-00753.
    >> Share

  62. MA F, Yang X, Zhou M, Bai M, et al
    Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide.
    J Nephrol. 2020 May 23. pii: 10.1007/s40620-020-00752.
    >> Share

  63. ZHANG J, Mi Y, Zhou R, Liu Z, et al
    The TLR4-MyD88-NF-kappaB pathway is involved in sIgA-mediated IgA nephropathy.
    J Nephrol. 2020 May 9. pii: 10.1007/s40620-020-00722.
    >> Share

    April 2020
  64. COPPO R, Robert T
    IgA nephropathy in children and in adults: two separate entities or the same disease?
    J Nephrol. 2020 Apr 20. pii: 10.1007/s40620-020-00725.
    >> Share

    March 2020
  65. VAN KRUIJSDIJK RCM, Abrahams AC, Nguyen TQ, Minnema MC, et al
    Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary? : Two case reports and literature review.
    J Nephrol. 2020 Mar 27. pii: 10.1007/s40620-020-00723.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016